# Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)

> **NCT05343793** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Stanford University** · enrollment: 47 (actual)

## Conditions studied

- Addiction, Opioid

## Interventions

- **OTHER:** Enhanced Monitoring and Feedback (EMF)
- **OTHER:** NIATx/MAT Academy
- **OTHER:** NIATx-Internal Facilitation (NIATx-IF)
- **OTHER:** NIATx-External Facilitation (NIATx-EF)

## Key facts

- **NCT ID:** NCT05343793
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-03-14
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2024-11-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05343793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05343793, "Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05343793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*